Literature DB >> 6235235

Biosynthesis of heparan sulfate proteoglycan by human colon carcinoma cells and its localization at the cell surface.

R V Iozzo.   

Abstract

After 24 h of continuous labeling with radioactive precursors, a high molecular weight heparan sulfate proteoglycan (HS-PG) was isolated from both the medium and cell layer of human colon carcinoma cells (WiDr) in culture. The medium HS-PG eluted from a diethylaminoethyl anion exchange column with 0.45-0.50 M NaCl, had an average density of 1.46-1.49 g/ml on dissociative CsCl density-gradient ultracentrifugation, and eluted from Sepharose CL-2B with a Kav = 0.57. This proteoglycan had an estimated Mr of congruent to 8.5 X 10(5), with glycosaminoglycan chains of Mr = 3 X 10(4) which were all susceptible to HNO2 deaminative cleavage. Deglycosylation of the HS-PG with polyhydrogen fluoride resulted in a 3H-core protein with Mr congruent to 2.4 X 10(5). The cell layer contained a population of HS-PG with characteristics almost identical to that released into the medium but with a larger Mr = 9.5 X 10(5). Furthermore, an intracellular pool contained smaller heparan sulfate chains (Mr congruent to 1 X 10(4)) which were mostly devoid of protein core. In pulse chase experiments, only the large cell-associated HS-PG was released (approximately 58%) into the medium as intact proteoglycan and/or internalized and degraded (approximately 42%), with a t1/2 = 6 h. However, the small intracellular component was never released into the medium and was degraded at a much slower rate. When the cells were subjected to mild proteolytic treatment, only the large cell-associated HS-PG, but none of the small component, was displaced. Addition of exogenous heparin did not displace any HS-PG into the medium. Both light and electron microscopic immunocytochemistry revealed that the cell surface reacted with antibody against an HS-PG isolated from a basement membrane-producing tumor. Electron microscopic histochemistry using ruthenium red and/or cuprolinic blue revealed numerous 10-50-nm diam granules and 70-220-nm-long electron-dense filaments, respectively, on the surface of the tumor cells. The results indicate that colon carcinoma cells synthesize HS-PGs with distinct structural and metabolic characteristics: a large secretory pool with high turnover, which appears to be synthesized as an integral membrane component and localized primarily at the cell surface, and a small nonsecretory pool with low turnover localized predominantly within the cell interior. This culture system offers an opportunity to investigate in detail the mechanisms involved in the regulation of proteoglycan metabolism, and in the establishment of the neoplastic phenotype.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235235      PMCID: PMC2113275          DOI: 10.1083/jcb.99.2.403

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  61 in total

1.  Cell-surface heparan sulfate. Isolation and characterization of a proteoglycan from rat liver membranes.

Authors:  A Oldberg; L Kjellén; M Höök
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

2.  Basement membrane glycoprotein laminin binds to heparin.

Authors:  S Sakashita; E Engvall; E Ruoslahti
Journal:  FEBS Lett       Date:  1980-07-28       Impact factor: 4.124

3.  Cartilage proteoglycans: comparison of sectioned and spread whole molecules.

Authors:  G K Hascall
Journal:  J Ultrastruct Res       Date:  1980-03

4.  Isolation of a heparan sulfate-containing proteoglycan from basement membrane.

Authors:  J R Hassell; P G Robey; H J Barrach; J Wilczek; S I Rennard; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

5.  Cell-surface heparan sulfate. Mechanisms of proteoglycan-cell association.

Authors:  L Kjellén; A Oldberg; M Höök
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

6.  Preliminary characterization of a xylose acceptor prepared by hydrogen fluoride treatment of proteoglycan core protein.

Authors:  C Coudron; K Ellis; L Philipson; N B Schwartz
Journal:  Biochem Biophys Res Commun       Date:  1980-01-29       Impact factor: 3.575

7.  Complexing of fibronectin glycosaminoglycans and collagen.

Authors:  E Ruoslahti; E Engvall
Journal:  Biochim Biophys Acta       Date:  1980-08-13

8.  Heparan sulfates from Swiss mouse 3T3 and SV3T3 cells: O-sulfate difference.

Authors:  K L Keller; J M Keller; J N Moy
Journal:  Biochemistry       Date:  1980-05-27       Impact factor: 3.162

9.  Oligosaccharides on proteoglycans from the swarm rat chondrosarcoma.

Authors:  L S Lohmander; S De Luca; B Nilsson; V C Hascall; C B Caputo; J H Kimura; D Heinegard
Journal:  J Biol Chem       Date:  1980-07-10       Impact factor: 5.157

10.  Biosynthesis of proteoglycans by rat granulosa cells cultured in vitro.

Authors:  M Yanagishita; V C Hascall
Journal:  J Biol Chem       Date:  1979-12-25       Impact factor: 5.157

View more
  44 in total

1.  Biosynthesis of glycosaminoglycans and proteoglycans by the lymph node.

Authors:  T J Brown; W G Kimpton; J R Fraser
Journal:  Glycoconj J       Date:  2000-11       Impact factor: 2.916

Review 2.  The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy.

Authors:  Stephen Douglass; Atul Goyal; Renato V Iozzo
Journal:  Connect Tissue Res       Date:  2015-07-16       Impact factor: 3.417

3.  Ultrastructural localization of keratinocyte surface associated heparan sulphate proteoglycans in human epidermis.

Authors:  R H Tammi; A M Hyyryläinen; H I Maibach; M I Tammi
Journal:  Histochemistry       Date:  1987

Review 4.  Structure and function of heparan sulphate proteoglycans.

Authors:  J T Gallagher; M Lyon; W P Steward
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

5.  The proteoglycan perlecan is expressed in the erythroleukemia cell line K562 and is upregulated by sodium butyrate and phorbol ester.

Authors:  S Grässel; I R Cohen; A D Murdoch; I Eichstetter; R V Iozzo
Journal:  Mol Cell Biochem       Date:  1995-04-12       Impact factor: 3.396

6.  Endorepellin affects angiogenesis by antagonizing diverse vascular endothelial growth factor receptor 2 (VEGFR2)-evoked signaling pathways: transcriptional repression of hypoxia-inducible factor 1α and VEGFA and concurrent inhibition of nuclear factor of activated T cell 1 (NFAT1) activation.

Authors:  Atul Goyal; Chiara Poluzzi; Chris D Willis; James Smythies; Adam Shellard; Thomas Neill; Renato V Iozzo
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

7.  HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses.

Authors:  Sonia D'Souza; Weidong Yang; Dario Marchetti; Caroline Muir; Mary C Farach-Carson; Daniel D Carson
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

8.  Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.

Authors:  Arivalagan Muthusamy; Carlton R Cooper; Ronald R Gomes
Journal:  BMC Biochem       Date:  2010-11-03       Impact factor: 4.059

Review 9.  A current view of perlecan in physiology and pathology: A mosaic of functions.

Authors:  Maria A Gubbiotti; Thomas Neill; Renato V Iozzo
Journal:  Matrix Biol       Date:  2016-09-06       Impact factor: 11.583

10.  Ultrastructural localization of the major proteoglycan and type II procollagen in organelles and extracellular matrix of cultured chondroblasts.

Authors:  R V Iozzo; M Pacifici
Journal:  Histochemistry       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.